#1SIDOMUNCUL COMPANY PRESENTATION UPDATE 9M21 SIDO IJ | SIDO JK Improving Health, Impacting Lives#2SIDOMUNCUL Disclaimer This presentation was prepared solely and exclusively for discussion purposes. This presentation and/or any part there of may not be reproduced, disclosed or used without the prior written consent of PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK (SIDO or the Company). This presentation, as well as discussions arising there from, may contain statements relating to future expectations and/or projections of the Company by its management team, with respect to the Company. These statements are generally identified by forward-looking words such as "believe", "expect", "may", "will", “plan”, “estimate”, “anticipate", or other similar words. These statements are presented on the basis of current assumptions which the company's management team believes to be reasonable and presumed correct based on available data at the time these were made, based on assumptions regarding the Company's present and future business strategies, and subject to certain factors which may cause some or all of the assumptions not to occur or cause actual results to diverge significantly from those projected. Any and all forward looking statements made by the Company or any persons acting on its behalf are deemed qualified in their entirety by these cautionary statements. This presentation is solely for informational purposes and should in no way be construed as a solicitation or an offer to buy or sell securities or related financial instruments of the Company. 2#3Table of Contents 1 Introduction 2 Company Highlights 3 4 Business Update 9M 2021 Financial Summary 5 Appendix SIDOMUNCUL 3#4SIDOMUNCUL ACE MUSCAR PROVEN TOLAKANGIN OBAT HERBAL UNTUK MASUK ANGIN+MADU SIDOMUNCUL SIDOMUNCUL TOLAK ANGIN Echinacea Meniran Valerian Ginting Mady Flu SIDOMUNCUL TOLAKLINU mint herbal Membantu m Pegal Linu & N INTRODUCTION Making Lives Brighter#5Largest herbal product manufacturer in Indonesia with leading product portfolio and strong financials SIDOMUNCUL Well-established Presence Attractive Financials 70+ More than 70 years of heritage Market Cap: USD1.6bn (Listed since 2013) 2020 Sales: USD 236.5mn 2020 NPAT: Numerous Accolades BEST of the BEST COMPANIES FORBES - Asia Best Under a Billion & 50 Best of the Best Companies (2020) Products that cater to Indonesian consumers across all demographics (gender, age and income groups) 122 distribution points throughout Indonesia More than 4,000 employees $ USD 66.2mn 2017-20 CAGR Sales: +9% NPAT +21% OP Margin: 35% NPAT Margin: 28% ROA: 24% ROE: 29% Stable dividend payout ratio averaging >90% (FY20: 100%) and debt free balance sheet A BEST BEST Market data as of 30 Dec 2020, FX of 14,105 IDR/USD. Finance Asia- - Indonesia Best Managed Listed Company & Best CEO (2021) * BRAND PLATINUM TOP BRAND GOLD PROPER - The highest recognition from the Ministry of Environment and Forestry Various other Indonesia most valuable brand awards and recognitions in ESG 150#6Established to preserve Indonesian heritage through innovation, local knowledge and passion for good JELIS SIDOMUNCUL Founded by Mrs. Rakhmat Sulistio in 1940 with the first formula of Jamu Tolak Angin. In 1951, the company SIDO MUNCUL was established Modern production facility was installed in Lingkungan Industri Kecil (Semarang, Central Java) to meet growing market demand New 32 ha factory complex in Klepu, with facilities having CPOB, CPOTB, and various ISO standards, was inaugurated BERLICO FARMA Dedicated for a better life! Acquired PT Berlico Mulia Farma to expand business to pharmaceutical industry HALAL لاوكتين ADONES Received Halal Certificate from Indonesian Ulama Council (MUI) and Implementation of Polymerase Chain Reaction (PCR) 1940 1970 1984 1997 2000 2013 2014 2018 2019 2020 PT Industri Jamu dan Farmasi Sido Muncul was officially incorporated Cornerstone-laying was held for the construction of a new, bigger, and modern factory complex in Klepu, Central Java 904 MURSUL www wwww. RAD-OC Conducted Initial Public Offering with issue price of Rp580 per share. Ticker code: SIDO Completed construction of a new, integrated herbal liquid production facility, with capacity of up to 180mn sachets/month. First shipment to the Philippine Received GOLD PROPER award from Indonesia ministry of environment and forestry. Completion of RTD production facility. 6#7Comprehensive range of products with strong brand equity and awareness among Indonesian consumers SIDOMUNCUL • • More than 300 SKUs Herbal & Supplement Food & Beverages 15:RALIMU KON DOMP Susulahe Kuk Ku KukuBima ENERG Kopijahe a TOLAK ANGIN ahe Dangi folaxin IMUCO Pharmaceutical Linu Go SUPRABION Licokal dolo-licobion 64% OF REVENUE Modernized "JAMU", using a wide range of natural Indonesian herbs and medicinal plants, with proven and long history of efficacies Herbal-based supplements to meet the modern lifestyle of Indonesian consumers 32% OF REVENUE Pioneer of fruity flavor energy drink in Indonesia, not just an energy booster but also a refreshing drink Wide variety of herbal-based drinks and confectioneries. Some with health maintenance benefits 4% OF REVENUE Various over-the-counter drugs and consumer health products (~60% contribution), and prescription drugs (~40% contribution) Scientific and Consumer Driven Innovation 7#8Experienced management team with proven track records in business and the industry Board of Commissioners SIDOMUNCUL President Commissioner Jonatha Sofjan Hidajat >40 years experience in herbal business Commissioner Johan Hidayat >40 years experience in herbal business Commissioner Sigit Hartojo Hadi Santoso >40 years experience in herbal business Commissioner Young Taeg Park >35 years experience in financial industry, now serves as Chairman and Managing Partner Affinity Equity Partners Commissioner Eric Marnandus >20 years experience in financial and consulting companies, now serves as Executive Director at Affinity Equity Partners Indonesia Independent Commissioner Prof. Lindawati Gani >30 years experience in finance accounting & audit. Also, serves as committee audit in several Indonesia plc Independent Commissioner Dr. M. Adib Khumaidi SPOT >20 years as doctor and Orthopedics Traumatology Specialist Independent Commissioner Segara Utama >45 years experience in financial industry. Also, serves as commissioner in several companies Board of Directors President Director David Hidayat Director Irwan Hidayat Director Leonard Director Darmadji Sidik >35 years experience in herbal business, expertise in operational >40 years experience in herbal business, expertise in marketing >20 years experience in finance, audit, taxation and IT at several reputable companies >20 years experience in sales and logistics at a reputable consumer company#9SIDOMUNCUL A ak hat alnya An Anak Sehat Herbalnya Anak COMPANY HIGHLIGHT Rasa Strawberry GRATIS!! 10 1 oc Anak Sobat di dalam 7 Making Lives Brighter#10SIDOMUNCUL Key company highlights 1 Leading player in the fast growing Indonesia consumer health market Since 1951 SIDOMUNCUL 2 Continuous product and business innovation 3 4 5 Track record of successful and systematic market penetration Fully-integrated and high quality supply chain, including best-in-class production facility with pharmaceutical grade certification and advanced technologies Commitment to continuously deliver value to all stakeholders 10#111 Leading player in the fast growing Indonesian consumer health market and #1 player in herbal segment ✓ Cultural preference for herbal- based and natural products Prevalent light digestive and respiratory ailments due to climatic and micro-climatic conditions CAGR 2019-14 10.3% 9.3% 8.9% 38.3% 8.3% 4.9% SIDOMUNCUL 16.7% 12.8% 13.5% 4.0% Herbal Vitamins and Products Supplements OTC Sports Weight Nutrition Management SIDO A B C D A Compelling demographic and cultural drivers B Herbal has the fastest growth within consumer health segment C SIDO is the market leader in the "JAMU" industry.* Cold Symptoms: 55% Heatiness: 30% Digestion: 5% Herbal Analgesics: 5% Others: 5% D Pre-cold is the most consumed category in herbal segment E Source: Nielsen (2020) & Company Research. * Total Sales Volume of Jamu Industry-Nielsen FY 2020. Since 1951 SIDOMUNCUL Iconic brands synonymous with herbal consumer health in Indonesia FL Others ~28% TOLAK ANGIN ~72% Market leader in herbal cold symptoms product category 11#121 Tolak Angin is the #1 herbal product in Indonesia SIDOMUNCUL TOLAK ANGIN® OBAT HERBAL UNTUK MASUK ANGIN Sido Muncul has demonstrated the industry-leading capabilities in herbal medicine, through coordinated multi-pronged strategy ensuring sustainable long-term growth 8 Formulation Innovation • First herbal producer to modernize the production of herbal medicines, creating a major, standardized brand • Innovative and convenient liquid single-use sachet accelerated market penetration, while also introducing other forms to expand consumer base % Extensive Network Creating Access Strong relationship with local distributors nationwide - easily accessible even at local mom and pop stores, as well as modern channels • Rapid penetration into global markets, including the Philippine and Nigeria Improving the Customer Experience Reformulating Tolak Angin forms to efficiently attract and target younger generation customers Significant focus on improving customer experience and perception of taste for herbal medicine • Tolak Angin is consumed by customers across all demographics Innovative and Proven Marketing • Successful 2015 marketing campaign educated consumers on using product as preventive measure vs. instant relief, boosting consumption frequency • Use of catchy taglines with elite celebrities also increased the frequency of product consumption Quality and Certifications • The first herbal player to obtain BPOM* standardized certification - Enables product to be distributed nationally, and enter modern trade • Among few herbal medicines to receive 'scientifically proven' certification ⚫ Owns full IP rights since 2018, with improved gross margin TOLAKANGIN® LIQUID HERBAL SUPPLEMENT "I trust Tolak Angin!" New TELAK ANGIN TOLA ANGIN Pris SADUND SIDOMUNCUL National Agency of Drug and Food Control (Badan Pengawas Obat dan Makanan). 12#131 Kuku Bima Ener-G! is the pioneer of fruit flavored energy drink in Indonesia SIDOMUNCUL Going against the industry norm of energy drink formulation, taste and color, Kuku Bima Ener-G! revolutionized the category by "thinking outside the box" ENER ARR-61 ERBAL Innovative ✓ From Jamu product extended to energy drink category Launched in 2004, Kuku Bima Ener-G! introduced powder energy drinks with various fruit flavors and quickly became a leading player in the energy drink category in Indonesia Kuk Kul ENE ENE Kuki ENER Iconic ✓ ROSA! is the brand tagline, which means STRONG in Javanese, and has become an iconic slogan Most of the product's advertisement carry Indonesia tourism theme, to introduce Indonesia culture to consumers ✓ Top 2 energy drink player in the country with >40% market share in its category Ku KukuBima ENER-G! Ginseng ENE Future ✓ Ready-to-Drink format offers increased convenience for younger consumer segment Further expansion into international market, especially in Nigeria and Malaysia KUKUB ENER FRESH OR KUKUBIMA JBIMA ENER-GER-G ROYAL GRAPE BERRY INERGY DRINKS kukoB ENLIG LINDONESIA 13#142 Product portfolio expansion through continuous product innovation SIDO launches 2-3 new products or variants annually Herbal & Supplement Food & Beverages SIDOMUNCUL NATURAL SAMBILOTO Ekstrak Andrographis paniculata Herba 350 mg ✔Membantu memelihara kesehatan & daya tahan tubuh POM TR 21231331 HEALTH SIDOMUNCUL PLEMENT Fish Oil 1000mg Membantu memelihara kesehatan POM SD 12 355 94 50 VEGETABLE CAPSULE 50 SOFTCAPSULE HEALTH SIDOMUNCUL CoQ10 COENZYME Q10 75mg POM 10 252 256 41 50 SOFTCAP SIDOMUNCUL NATURAL 24 kapsul KAPSUL JSH 00000 POM. TR. 202376441 UL INDONESIA SIDOMUNCUL TeJamu Ramuan minuman tradisional untuk kesehatan SAMANT EMPON TEMU LAWAK SECAN 5 sachet POM 14 262264131 JAMU HERITAGE Kunyit Asam JAMU HERITAGE BERAS KENCUR TeJamu laman minuman tradisions untuk knechatan 150 SIDOMUNCUL tamin C10002 SDOMUNCUL +Z inc Orange Honey VILEVIL. 83 Vit B HCI, Vit B12 • SIDO's new product development engine is driven by strong local market insights and understanding of customers' needs and preferences, coupled with superior R&D in herbal medicine • This has enabled us to constantly bring new innovative products to develop new market niches 14#15• • • 2 Entry to the pharmaceutical industry through acquisition of PT Berlico Mulia Farma SIDOMUNCUL Expansion into the pharmaceutical sector resulted in complementary organic growth SIDO acquired PT Berlico Mulia Farma ("Berlico") in 2014 Key strategic rationale was to leverage the complementary value proposition of herbal and pharma products resulting in a wider portfolio of consumer health products Berlico has its indpendent manufacturing facility which produces >80 product SKUs, from OTC drugs, consumer health products (pharmaceutical supplements and topical medicines), to prescription drugs A distribution network covering 16 major cities in Indonesia Anacetine Paracetamol Quasi Chloramine Maale Sirup Batuk & Flu Anacet Anacetine Anacetine PLUS Chlorpheniramie Phenypanca Belak & Fix Anacetine (medicine to reduce fever for kids) Suplemen Makanan SUPRABION VITAMIN DAN MINERAL OBH BERLICO JERUK NIPIS Succus LIQUIRITIAE AMMONIUM CHLORIDE GBH BERLICO JERUK NIPIS MINYAK MINYAK TELON Tiga Asak TELON Tiga Anak strup 100 ml OBH Berlico (medicine for cough) Minyak Telon Tiga Anak (Ointment for baby & kids) Berlosid Al. Hydroxide, Mg. Hydroxide, Dimethicone 10 strip 10 tablet kunyah Obat Maag Suprabion (blood booster multivitamin) Berlosid (medicine for gastritis) Licokalk SUPLEMEN MAKANAN Licokalk KOMPOSIS AKG kan det 2000 an GATAN DAN PERAN CARA PENYIMPANAN winding BA Licokalk (calcium multivitamin) AN 15#163 Track record of successful and systematic market penetration SIDOMUNCUL • Strong distribution network (Distribution points) ■ Targeted expansion across Java Leverage strong understanding of Javanese consumer tastes and preferences ■Relatable brand heritage Establishment of extensive pan-Java distribution network, with 122 sub- distributors nationwide and access to >100,000 wholesalers & retailers and >2 million POS West Indonesia expansion East Indonesia expansion Maximizing the Potential Established Leadership in Indonesia Increase # of Active Outlets SEA and Africa expansion ■ Focus Export Countries: Philippine, Nigeria, & Malaysia On-the-ground presence in Philippines through branch office and subsidiary in Nigeria Marketing support to establish the brand awareness and product knowledge The Opportunity Increase MT Implementing Contribution SFA Intimate consumer #1 Traditional Entrenched Herbal distribution understanding Supplement network Replicate Indonesia success Market adjacencies Focused approach brand 16#174 Best-in-class production facility with pharmaceutical- grade certification and advanced technologies • • Sido Muncul Facility Main operation is located in Klepu, Central Java, over a 32 ha land area, manufacturing all Herbal and F&B products Total liquid herbal production capacity of up to 180mn sachet per month, after completion of new herbal manufacturing plant in 2018. Post expansion, utilization rate for herbal production facility is still ample at around 50% • New 1 ha raw material storage warehouse with storage capacity of 6-month inventory • Commissioning a new RTD manufacturing plant . • SIDOMUNCUL Semarang Herbal Indo Plant Main facility to extract all herbal raw materials into liquid or powder products New extraction facility was completed in 2017, with higher extraction yield, larger capacity and improved efficiency in raw materials usage ISO M Hararg HACCP حلال IND DO Wini • Certifications GMP standard for Traditional Herbal Medicine (CPOTB) and Pharmaceutical (CPOB) • ISO 9001 for quality management system, ISO 22000 for food safety management, and ISO 17025 for laboratory management system • Hazard Analysis & Critical Control Point (HACCP) to identify food safety risks, prevent hazards in food safety, and convey legal compliance • Halal certification for over 200 SKU products • • Berlico Mulia Farma Located in Yogyakarta (near Central Java) Manufacturer of the entire pharmaceutical product range, including solid, semi-solid, and liquid formats Pharmaceutical GMP standard (CPOB) 17#185 Strong financial profile SIDOMUNCUL Financial performance of SIDO has exhibited consistent growth and profitability resulting in financial efficiency Steady sales growth... ...coupled by improving profitability USD mn¹ USD mn¹ 33% 35% CAGR: +9% 30% 25% 2017-19 CAGR: EBIT: +22% 236 28% NPAT: +21% 217 26% 24% 196 182 21% 82 73 66 58 57 45 47 38 2017 2018 2019 Resulting in best-in-class returns... 2017 2018 2019 2020 2020 EBIT NPAT EBIT Margin NPAT Margin ...and strong cash position with no leverage USD mn¹ 29% 26% 24% 23% 23% 20% 18% 17% 73 64 61 57 2017 2018 2019 2020 2017 2018 2019 2020 ROA ROE 1FX of 14,105 IDR/USD 18#19200 300 Jan-18 700 800 IDR/share 1000 900 SIDOMUNCUL 600 5 Focus on shareholder return SIDOMUNCUL SIDO has embarked on a transformation journey to deliver shareholder value, with plenty of strategic initiatives still to be completed Appointed David Hidayat as the new CEO along with new, professional BOD members ANGIN 500 400 Transfer of trade secret formulations to SIDO & termination of 1.5% royalty fee First export shipment to the Philippines Feb-18 Mar-18 GRI Empowering Sustainable • ABONE Commercial production of the new liquid herbal facility in Klepu Received Halal Certificate DO MUNCUL T 2019 Forbes First export shipment to MN MUNCUL Nigeria under NIGERIA Muncul Nigeria Ltd Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19 12.2 First Annual FY18 Sustainability Report, in accordance with GRI Standards BEST BEST FORBES Asia Best Under a Billion & 50 3.1 3.9 COMPANIES Best of the Best Companies FY18 FY19 FY20 Indonesia 1st COVID-19 55 Stock split 1:2 Best of the Best Award case 30th Anniversary Mudik Bersama SIDOM Indonesia 1st large-scale social restriction (PSBB) Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20 Jul-20 ADTV (IDR bn) 71.1k Gold Proper Award 6.7k 12.2k FY18 FY19 FY20 First export shipment to Saudi Arabia Aug-20 Sep-20 Oct-20 Nov-20 Dec-20 Number of Equity Shareholders 11 S 6 FY18 FY19 FY20 Indices Inclusion in IDX (Excl. JCI) 19#20чтоё Style SIDOMUNCUL Making Lives Brighter HERBAL DRIN Kunyit Asa Jamoe Life Style DON HERBAL DRIN Kulit Mangas MEMBANTU MEMELARA DAVA TALAN TUSCANY BUSINESS UPDATE 9M 2021#21SIDO delivered stellar performance in 3Q21 Highlights of financial results Strong and diversified revenue growth (IDR bn/%growth yoy) Continued margin improvement Revenues +41% 1,122 798 SIDOMUNCUL A. Favourable (IDR bn/%margin) NPAT +23% consumer trend +35% B. Sustained growth 31% 2,776 from leading Stable raw material prices 865 28% 2,257 products and +60% distribution 641 expansion 32% 28% C. Higher contribution 363 Operational excellence • Effective cost management from new products 227 9M20 9M21 D. Embracing digital channel 3Q20 3Q21 9M20 9M21 3Q20 3Q21 Healthy financial position (IDR tn) Cash Balance 1.25 1.03 1.03 0.80 0.82 Solid balance sheet with strong cash generation 3Q20 4Q20 1Q21 2Q21 3Q21 • Zero leverage Higher dividend distribution (IDR/%payout) Final DPS 100% 90% 31 81% 25 25 81% 80% 18 15 13 2016 2017 2018 2019 2020 • Increasing shareholder value 21#22Ⓐ Indonesia has successfully weathered COVID-19 2nd wave due to the Government's decisive and swift response SIDOMUNCUL Higher vaccination penetration, record low infection rate, and loosening mobility restriction should help accelerate economic recovery and promising growth outlook from 4Q21-onward. Indonesia COVID-19 Cases & Vaccination Consumer Confidence Index Rate ('000) 110 New COVID Cases Vaccination Rate 60 20% 105 50 40 40 100 15% 96 95 30 10% 90 20 20 10 1-Jul 16-Jul 31-Jul 15-Aug 30-Aug 14-Sep 29-Sep 85 5% 80 60 75 0% 15 Jun-20 Sep-20 Dec-20 Mar-21 Retail Sales Value Growth TTM 13Q 40% 40% 13% 12% 11% 8% |10% 9% 5% 3% 2% 1% 0% Jun-21 Sep-21 FMCG FOOD 1-2% BEVERAGES PERSONAL CARE HOMECARE HEALTHCARE • . Prolonged COVID-19 pandemic makes consumers more aware of their health and wellness. Surging demand from the market has made Healthcare and Pharmaceutical sector increased beyond other FMCG sectors. Declining COVID-19 cases and improving economy are helping improve consumer confidence. In combination, these factors will support continued strong demand for herbal supplements and multivitamins as consumers want to maintain their immune system and healthy lifestyle. source: Bank Indonesia, Covid19.go.id, Company Estimation PHARMACEUTICAL 22 22#23Ⓑ Sustained high demand for immunity-boosting supplements and distribution penetration efforts have boosted SIDO's performance SIDOMUNCUL SCIENTIFICALLY Jahe wen SIDOMUNCUL SCIENTIFICALLY PROVEN TOLAKANGIN OBAT HERBAL UNTUK MASUK ANGIN + MADU SIDOMUNCUL PROVEN TOLAKANGIN OBAT HERBAL UNTUK MASUK ANGIN + MADU INDONESIA DONESIA NO. 00130094420319 | Isi: 12 sachet @ 15 ml POM HE 122 600 301 NO 00130094420319 Isi: 12 sachet @ 15 ml POM HE 122 600 301 SIDOMUNCUL SIDOMUNCUL SusuJahe Kopijahe susu ekstrak johr-gule Kunyit Asam BERAS KENCUR TeJamu SIDOMUNCUL Vitamin C 10 SHOMUNCUE Vitamin C 1000.. S.DOMUNCUL SIDOMUNCUL +2 mc • Tolak Angin sales increased more than 40% yoy for 3Q21 and more than 20% for 9M21 versus 9M20. • Campaign story that makes clearer the benefits of Tolak Angin for immunity brought TA sales volume to the next level. BAYA TAHAN TUBUH MEGHATTIS H 7306 • • Healthy drink products continued to book solid performance with growth of 48% yoy for 9M21. Vitamin C drink increased more than 250% yoy for 9M21 and has become #2 in MT channel based on sales volume. New Susu Jahe variant: Susu Jahe Super with red ginger as the main ingredients, good for maintaining health. • • SIDO's outlet coverage has reached around 131k wholesalers and retailers as of 9M21. Outlet coverage expansion continued, with more than 50% of new outlets contributed by East Indonesia. Focus of the expansion is on product availability and accessibility improvement nationwide. Number of Outlet Coverage SIDOMUNCUL SusuJahe Saper *) Total market size of Vitamin C in Indonesia is ± IDR 4 trillion 131k 113k 80k 2019 2020 9M21 23 23#24The diversification strategy with new products (NPD) have generated excellent sales growth and set solid fundamental for the future • NPD has grown more than 140% qoq as of 3Q21, supported by strong sales of Vitamin C1000 new flavour and RTD variants, also by new supplement products (soft gel, JSH, Sambilito, etc.). NPD contributes 4% of total consolidated sales. • For the last 3 years, SIDO new products have grown significantly by 51% CAGR, without cannibalizing the existing products as each of the new products addresses different symptoms and efficacies. SIDOMUNCUL Positive sales trend on NPD* (IDR bn) 70 60 50 HN WAGON 10 40 30 20 SALES CAGR 2017-2020 NEW PRODUCTS SIDO 9% HERBAL 10% F&B 8% *New Products launched in 2020-2021 51% 3Q20 4Q20 1Q21 2Q21 3Q21 Vit C is the top contributors of NPD* VIT C1000 66% OTHER 7% SUPPLEMENT 27% 24#25D SIDO has cooperated with >20 marketplaces in Indonesia Leveraging online marketplaces' broad exposure (B2C & B2B) SIDOMUNCUL Reaching out to new customers through thematic marketing campaign and promotion Loads LIVE Bour THEN SONNES MANISA BEMOWAN RISIDORIUNCUL Harplast KOLABORASI EKSKLUSIF Rasakan Kehangatan Berbagi Keceriaan > Softex. REBALAN PATRICUL CLNAWAN Palicia qua REBAHANGUNAWAN H Side und Min Kun Kolaborasi Eksklusif Datang Bulan Aman, Nyaman Berkegiatan September 2021 Jun Ma De Sp. 720 TERMIN Sontex Dan Sirih GRATIS Developing brand awareness and product diversification w < Rash Dad 4 SEHARI GRATIS ONGKIR AAT DITE "POLDER W HWNI 05:01:12.5 P BIKIN макин H TADIUNILE Ото - Sidomunal Makin Semangat dengan Tubuh Sehat 69. 25. Pp249.000 Rp175.500 R145.500 Voucher Spesial Untukmu! Cashback Rp10 Cashback 15 14 п 14 Cashback 20% 25 Cashback Rp7,5 MELICATED FOURNI Garlic Fatraper Echinacea Lingzhi Hepacom Hermons 300 • Herbal supplement products are #1 Powdered contributor of SIDO online sales. Jamu 6% Other 11% 535 SIDOMUNCUL TOLAKANGINT SIDOMUNCUL Vitamin E100 SIDOMUNCUL SARI KUNYIT 629 SIDOMUNCUL Vitamin D3 400 SIDOMUNCUL Vitamin E300 SIDOMUNCUL TOLAKLINU Diverse needs of online customers have brought opportunity for SIDO to expand product diversity and increase brand awareness of herbal supplement portfolio. Vit-C 1000 8% SIDO's Best Herbal Selling Products Supplement via Online 57% Tolak Angin 19% 25#26Corporate Update on 3Q 2021 Jakarta, 3 September 2021 M SEMARANG HERBAL INDO PLANT KukuBima ENER-G! PT. MUNCUL MEKAR TOLAK ANGIN TOLAKLINU AlangSari Untuk Panas Dalam plus SIDOMUNCUL Vitamin C 1000. KAPSUL JSH Charcoal Extract 100 mg) BERLICO FARMA SIDOMUNCUL SusuJahe SIDOMUNCUL ESEMAG Herbalnya LAMBUNG MUN NIGE SIDOMUNCUL KopiJahe SIDOMUNCUL 000. madusido SIDOMUNCUL Completed installation of 2 MWp Solar Panel in factory area Corporate action update: . • SIDO distributed interim dividend on Aug 27, with amount of IDR 15.30 per share or IDR 455.48 bn in full amount (90.7% payout ratio of 1H21 Net Income). Shareholders approved to distribute bonus shares with ratio of 131:1 from the results of EGMS on Sep 3. Around 217 mn bonus shares had been distributed on Oct 5. Solar PV Produce* 2,336 MWh/Year *estimated yield of electricity generated = CO₂ + 1,900 Tons CO2 Reduction of Carbon Emissions 27,374 Trees Seedlings Grown for 10 Years 26#27Efforts in sustainable initiatives implementation have been fruitful SUSTAINALYTICS • Sustainalytics upgraded SIDO ESG rating to LOW RISK • The rating upgrade is based on strengthening and implementation on ESG policy and improvement on public disclosures regarding initiatives and programs along with the progress and achievements, increase commitment by having specific targets, such as: emission reduction, energy & water efficiency, etc. SIDOMUNCUL GREEN INDUSTRY - LEVEL 5 - • SIDO received the Green Industry level 5 award for the 4th times. Green Industry Level 5 is the highest awards, awarded by Ministry of Industry Indonesia, for the company's efforts in attribute to production efficiency and environmentally friendly. · Aspects of the assessment on the production process, emissions & waste treatment, and company management got a high score with total of 91 out of 100. PENGHARGAAN INDUSTRI HIJAU 201 merintah Republik Indone Kepada Industri Jamu dan Farma Sido Muncul Tbk LEVELS 27#28KAPSUL JSH 100 SIDOMUNCUL NATURAL Men esa dog SIDOMUNCUL KAPSUL JSH Charcoal Extract 100mg 00000 Produk INDONESIA Making Lives www.sidoruralsore.com 50 Vegatable Capsules SIDOMUNCUL NATURAL KAPSUL JSH Charcoal Extract 100 OM TR 2016 Vep Brighter 00000 INDONES SIDOMUNCUL FINANCIAL SUMMARY#29Benefiting from strong demand of herbal supplement & vitamin products, SIDO continued delivering strong results up to 9M21 (IDR Billion - Unaudited) 9M21 SALES SIDOMUNCUL GROSS PROFIT EBIT NPAT 2,776 1,562 1,079 865 +23% YoY +28% YoY +37% YoY +35% YoY 9M20 2,257 1,217 786 641 · Surging demand from domestic market boosted SIDO topline performance in 3Q21 (+41% yoy). Tolak Angin group and Healthy Drink products were the top growth contributors. • Overall export sales increased by 39%, contributing 2.6% of total sales as of 9M21. Nigeria and Malaysia are still top export contributors as of 9M21. A&P cost ratio was stable at 9% of sales. Overall, OPEX ratio to sales was 18%, lower compared to historical ratio (20%-21%) due to higher sales performance and efficient operations. SIDO continued to improve its margin and booked higher NPAT growth of 35% with margin of 31%. 29#30SIDO has a healthy and solid balance sheet (IDR Billion - 2018-2020 (Au), 9M21 (Un)) Cash & Cash Equivalents 865 806 1,032 SIDOMUNCUL Capital Expenditure Target CAPEX '21 200 127 106 825 74 2019 2020 Dividend Per Share DPS • %Payout CAGR 2020-2018 +32% 9M21 31.4 +22% 24.5 2018 2019 2020 9M21 15.3 12.5 18.0 100% 90% 90% 91% 81% 2018 2019 2020 Interim'20 Interim'21 30#31SIDOMUNCUL Positive outlook for Herbal and Supplement industry as consumption has become habitual for Indonesian consumers to keep them healthy Herbal Medicine Market Outlook Vitamin & Supplement Market Outlook (IDR tn) 20 15 10 10 CAGR 2020-25F: +6% (IDR tn) 45 35 25 15 5 5 2018 2019 2020 2021F 2022F 2023F 2024F 2025F CAGR 2020-25F: +8% 2018 2019 2020 2021F 2022F 2023F 2024F 2025F • ⚫ Trust towards local wisdom with JAMU as the natural remedies for health support has been growing for the past decades along with the trend of natural lifestyle. E-commerce has a big role in the development of herbal supplements market, not just as platforms to sell the products but also to provide product education. • Vitamins have bright outlook and huge market opportunities especially post-Pandemic, with soaring demand for extra immune booster products from the market. Vitamin C and D are still expecting to be consumers' primary choice to support and maintain health. The positive trend of Herbal and Supplement consumption will be supported by Indonesia's rising. middle class and demographic bonus. source: Company Research & Estimation 31#32Optimistic future with double digit target in 2022 SIDOMUNCUL With potentially fast economic recovery and increased focus on healthy lifestyle, SIDO is optimistic to face 2022 and aims to deliver double digit growth both for top and bottom line. Growth Guidance 2021: Sales >15% and NPAT >25% Maintain margin and improve business Growth guidance 2022: Sales & NPAT ~15% Optimizing domestic distribution Strengthening and products diversification Focus on export recovery and expansion digital presence in online platforms and process marketplaces CAPEX IDR 180 - 200 billion Key Takeaways: • Successfully navigated all the challenges and uncertainties in 2020 and 2021 and continued delivering double digit growth. • More experienced and agile leadership team to face the challenges up ahead and execute the strategy consistently. Additional points: SIDO has ample production capacity from 2018's major expansion and is ready to seize surging market demand in 2022. Total utilization rate is currently at 60%-65%. 32#33VESICOMUNCUL KukuBima ENER-G! vitamin 1000 mu Anggun ZukuBima ENER-G! 1000 KUKUBIMA ENER-G RED BERRY ENERGY DRINK VITAMIN D3 R, B 300 ml Making Lives Brighter 103 APPENDIX SIDOMUNCUL#34P/L Statement - 9M 2021 SIDOMUNCUL IDR Billion - Unaudited SALES COST OF GOODS SOLD GROSS PROFIT %Margin 9M21 9M20 Δ %gr. 2,776 2,257 519 23% (1,215) (1,040) (174) 17% 1,562 1,217 345 28% 56% 54% 2% Selling & Marketing Expenses (356) (305) (51) 17% General & Administrative Expenses (144) (134) (10) 7% Other Operational Expenses / Incomes 17 9 8 95% OPERATING PROFIT 1,079 786 292 37% %Margin 39% 35% 4% Finance Income 31 37 (6) -18% Finance Cost (1) (0) (0) 101% PROFIT BEFORE INCOME TAX EXPENSES 1,108 823 286 35% %Margin 40% 36% 3% Income Tax Expense - Net (243) (182) (61) 34% PROFIT FOR THE YEAR 865 641 225 35% %Margin 31% 28% 3% 34#35Subsidiaries to support vertical integration of operations from upstream to downstream Solid operation support from subsidiaries to answer customer demands SIDOMUNCUL PT HOTEL CANDI BARU (60.5%) CONCORDANT INVESTMENTS (21.1%) SIDOMUNCUL *PUBLIC (18.4%) PT. MUNCUL MEKAR The commencement of operation: 1987 Business activities: Trading SEMARANG HERBAL INDOPLANT The commencement of operation: 2009 Business activities: Herbal Extraction BERLICO FARMA The commencement of operation: 1993 Business activities: Pharmaceutical MN MUNCUL NIGERIA The commencement of operation: 2018 Business activities: Trading *Including 12.2mn treasury shares 35#36SIDOMUNCUL PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK HEAD OFFICE: - Office Sido Muncul, Lt 1 – Gedung Hotel Tentrem JI. Gajahmada No. 123 Semarang Indonesia - BRANCH OFFICE: Grha Muncul Mekar, fl. 8th Jl. Panjang Arteri Kelapa Dua, No. 27 Kebon Jeruk Jakarta Barat - Indonesia EMAIL: [email protected] WEBSITE: https://investor.sidomuncul.co.id/en/home.html